Szeged, Hungary

Gabor Tamas



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabor Tamas: Innovator in Pharmaceutical Compounds

Introduction

Gabor Tamas is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on compounds that have potential medical applications.

Latest Patents

Gabor Tamas holds a patent for 8-hydroxy-quinoline derivatives. This invention relates to compounds of the general formula (I) and their pharmaceutically acceptable salts. In this formula, R represents a hydrogen atom, lower alkyl group, lower alkenyl group, lower cycloalkyl group, aryl group, aralkyl group, or heterocyclic group. The above groups can be optionally substituted in ortho, meta, and/or para positions with 1, 2, 3, or 4 electron-withdrawing groups or electron-donating groups. The compounds according to the invention can be used in medicine, mainly for the treatment of diseases associated with neurological and/or oxidative stress. He has 1 patent to his name.

Career Highlights

Throughout his career, Gabor Tamas has worked with several companies, including Avidin Kutato, Fejleszto Es Kereskedelmi Korlatolt Felelossegu Tarsasag and Ubichem Kutato Korlatolt Felelossegu Tarsasag. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Gabor Tamas has collaborated with notable individuals in his field, including Laszlo Puskas and Csaba Szabo. These collaborations have likely enhanced his research and innovation efforts.

Conclusion

Gabor Tamas is a distinguished inventor whose work on 8-hydroxy-quinoline derivatives showcases his commitment to advancing medical science. His contributions to the pharmaceutical industry are noteworthy and reflect his innovative spirit.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…